Recombinant Keratin 10 antibody
Quick Overview for Recombinant Keratin 10 antibody (ABIN5707747)
Target
See all Keratin 10 (KRT10) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Purpose
- Recombinant CK10 Antibody / Rabbit Monoclonal (azide and preservative free)
-
Purification
- Protein A affinity chromatography
-
Immunogen
- A cytoskeletal preparation extracted from human ectocervical epithelium was used as the immunogen for the recombinant CK10 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
-
Optimal dilution of the recombinant CK10 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant CK10 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Keratin 10 (KRT10)
-
Alternative Name
- CK10
-
Background
- This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation, it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.
-
UniProt
- P13645
Target
-